THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED
UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014
WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL)
ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A
REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO
BE IN THE PUBLIC DOMAIN
6 June 2024
Versarien Plc
("Versarien", the
"Company" or the "Group")
Interim Results for the six months ended
31 March 2024
Versarien Plc (AIM: VRS), the advanced
engineering materials group, announces its unaudited interim
results for the six months ended 31 March 2024.
Financial
Summary
●
Group revenues of £2.50 million (2023: £2.62
million)
●
Graphene revenues of £0.28 million (2023: £0.09
million)
●
Grant income of £0.20 million (2023: £0.06
million)
●
Adjusted LBITDA* of £0.79 million (2023: £2.01
million)
●
Loss before tax of £1.77 million (2023: £3.40
million)
●
Cash of £0.70 million as at 31 March 2024 (30 September 2023:
£0.60 million)
*Adjusted LBITDA (Loss Before
Interest, Tax, Depreciation and Amortisation) excludes Exceptional
items and Share-based payment charges)
Operational
Highlights
●
Completed an agreement with MCK Tech (Korea) for the
exclusive licence of five CVD patents
●
Sold South Korean plant and equipment to MCK Tech (Korea) for
£604,000
●
Completed a know-how and manufacturing licence agreement with
Montana Quimica LTDA, a Brazilian multinational focussed on the
production of paints and wood finishing products
●
Entered into a mutual letter of commitment to support
Building for Humanity to provide 3D concrete printed materials for
social housing in Accrington
Stephen Hodge,
Chief Executive Officer of Versarien, commented:
"The re-focussing of the business to
its core graphene technology combined with a manufacturing-light
approach is beginning to bear fruit financially with losses
continuing to fall. We have a number of parties showing initial
interest in licensing our technology as well as progressing our
strategic relationships in core areas particularly construction
including 3D concrete printing. We remain optimistic about the
future as we continue to streamline our operations, capitalise on
our strategic partnerships and drive technological
advancements."
For further
information please contact:
Versarien
Plc
|
|
Stephen Hodge - Chief Executive
Officer
Chris Leigh - Chief Financial
Officer
|
c/o IFC
|
|
|
|
|
SP Angel
Corporate Finance LLP (Nominated Adviser and
Broker)
|
|
Matthew Johnson
Adam Cowl
|
+44 (0) 20 3470 0470
|
|
|
IFC Advisory
Limited (Investor Relations)
|
|
Tim Metcalfe
Zach Cohen
|
+44 (0) 20 3934 6630
|
|
|
Notes to
Editors:
The strategy of Versarien plc (AIM:VRS) is to
be a development-led advanced materials company focussed on
specific sectors that will lead to a manufacturing-light and
licensing model.
For further information please
see: http://www.versarien.com
Chair's
Statement
It is only a short time since we
updated the market with our Annual Report to 30 September 2023,
published on 28 March 2024, but nonetheless I am pleased to report
on further progress made.
The disposal of the two mature
businesses remains an ongoing process. Talks are at an advanced
stage with one party regarding the AAC plastics business, although
there can be no certainty that this will lead to a successful
sale.
The pipeline of opportunities
continues to grow and supports our view of reaching EBITDAE
positive during the second half of next year. Whilst the Group
still remains loss making at present it has made significant
progress on reducing its LBITDAE over the last 18 months from £2
million in the first half of the 2023 financial year, to £1 million
in the second half of the same period and now to £0.8 million in
the period under review.
I am grateful for the support we
continue to receive from both new and existing shareholders and to
all our staff as we continue to transition the business into an IP
led licensing model and look forward to updating the market on
future developments in due course.
Diane Savory
OBE
Non-executive
Chair
Chief
Executive Officer's Review
The first half of the financial year has marked
a significant period of strategic refocus and operational
efficiency for the Group. We have made considerable progress in
enhancing our core technology businesses and aligning our business
model towards a manufacturing-light approach. This shift is already
reflected in our improved financial metrics and the birth of new
strategic partnerships.
Graphene
developments
Our strategic partnership with Montana Quimica
LTDA (Brazil) with whom we have secured a know-how and
manufacturing licence agreement reinforces our presence in South
America. The sale of CVD graphene manufacturing equipment to MCK
Tech (South Korea) aligns with our manufacturing-light strategy and
provides working capital; the opportunity to remain operating in
the area of CVD graphene in collaboration with MCK Tech is
underpinned by our licencing agreements. We have further
strengthened relationships in Korea through supporting the
development of international standards for graphene and 2D
materials, funded by the Korea Evaluation Institute of Industrial
Technology (KEIT) until December 2028. KEIT is an organisation
dedicated to establishing a programme of international joint
research and development between research institutes of the
Republic of Korea and overseas organisations.
3D
construction printing developments
3D construction printing continues to gain
traction. We have delivered the "Physical and Mechanical Properties
of 3D Printed Concrete" report to the Office for Product Safety and
Standards, part of the Department for Business and Trade and have
recently signed a letter of mutual commitment to support the
"Charter Street Accrington" social housing project led by Building
for Humanity. This initiative represents the largest 3D housing
construction project in the UK, exemplifying our commitment to
innovation and sustainability. This project is a pivotal
opportunity to showcase Versarien's capabilities in enabling
low-carbon, efficient construction solutions. The project is due to
start during H2 2024.
Outlook
I extend my gratitude to our shareholders,
partners, and dedicated team for their continued support as we
navigate this phase of growth and innovation.
The re-focusing of our business
towards our core technology businesses and strategic collaborations
is bearing fruit. Our continued divestment from non-core activities
will see a reduction in overall revenues, but the notable increase
in graphene revenues and grant income, underscore our more focused
approach. We are witnessing a reduction in losses and a growing
interest in licensing opportunities that positions Versarien for
sustained growth and industry leadership. We remain optimistic
about the future as we continue to streamline our operations,
capitalise on our strategic partnerships and drive technological
advancements in the construction and leisure sectors.
Dr
Stephen Hodge
Chief Executive Officer
Chief
Financial Officer's review
The results for the period continue to show
reduced losses as we seek to transition the business into a
financially viable operation. The Technology Businesses have seen
an improvement in revenues to £277,000 from £87,000 in the
comparative period. In addition, income from grants awarded to
Gnanomat have resulted in an increase in other income from £54,000
to £202,000. Further information is given in note 2, segmental
information.
The change in strategy to a much-simplified
structure has resulted in a number of cost savings, including
exiting part of the lease at Longhope following the adoption of the
manufacturing-light strategy.
The mature businesses have seen a revenue
decline, albeit that AAC is now seeing signs of some reversal. The
disposal process for both Total Carbide and AAC Cyroma remains
ongoing. AAC is more advanced and its assets and liabilities
are now classified as "held for sale" and its results treated as a
discontinued operation albeit there is no certainty of
completion.
The adjusted LBITDA for operations is
calculated as follows:
|
Continuing operations
|
Discontinued
operations
|
Total
|
Continuing
operations
|
Discontinued
operations
|
Total
|
|
6 months
ended
31 March
2024
|
6 months
ended
31 March
2024
|
6 months
ended
31 March
2024
|
6 months
ended
31 March
2023
|
6 months
ended
31
March
2023
|
6 months
ended
31 March
2023
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
(Loss) from operations
|
(1,373)
|
(148)
|
(1,521)
|
(3,033)
|
(97)
|
(3,130)
|
Depreciation and Amortisation
|
324
|
35
|
359
|
594
|
89
|
683
|
Share based payments
|
147
|
-
|
147
|
264
|
-
|
264
|
Exceptional items
|
229
|
-
|
229
|
170
|
-
|
170
|
Adjusted
LBITDA
|
(673)
|
(113)
|
(786)
|
(2,005)
|
(8)
|
(2,013)
|
Adjusted LBITDA (which is not a GAAP measure
and is not intended as a substitute for GAAP measures and may not
be the same as that used by other companies) is a measure used by
management to reflect the core operating performance of the
underlying businesses rather than the effects of non-core financial
and non-cash expenses.
The reported loss before tax was £1.77 million
(2023: £3.40 million). Group net assets at 31 March 2024 were £0.98
million (30 September 2023: £1.08 million) with cash at the period
end of £0. 70 million (30 September 2023: £0.60
million).
Net cash used in operating activities was £0.77
million (2023: £1.83 million) and cash used in investing activities
was £0.02 million (2023: £0.14 million), net principal lease
payments were £0.24 million (2023: £0.35 million) and CBILS
repayments £0.04 million (2023: £0.05 million), giving total cash
outflows of £1.07 million (2023: £2.37 million). These outflows
were financed by net funds received from the share issues of £1.39
million (2023: £2.02 million).
The surplus of £0.32 million (2023: £0.35
million deficit) together with reduced drawings on the invoice
finance facilities of £0.22 million (2023: £0.24 million) resulted
in a cash increase of £0.10 million (2023: £0.59 million
decrease).
Going
Concern
The interim statements have been prepared on a
going concern basis as described in note 1, basis of
preparation.
Chris
Leigh
Chief
Financial Officer
Consolidated Interim Financial Statements
Group statement of comprehensive income
For the 6 months ended 31 March
2024
|
|
Continuing
operations
|
Discontinued
operations
|
Total
|
Continuing
operations
|
Discontinued
operations
|
Total
|
|
|
31 March
2024
Unaudited
£'000
|
31 March
2024
Unaudited
£'000
|
31 March
2024
Unaudited
£'000
|
31 March
2023
Unaudited
£'000
|
31 March
2023
Unaudited
£'000
|
31 March
2023
Unaudited
£'000
|
|
Notes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
2
|
1,338
|
1,159
|
2,497
|
1,400
|
1,221
|
2,621
|
Cost of sales
|
|
(834)
|
(955)
|
(1,789)
|
(1,153)
|
(985)
|
(2,138)
|
Gross profit
|
|
504
|
204
|
708
|
247
|
236
|
483
|
Other operating income
|
|
205
|
-
|
205
|
57
|
-
|
57
|
Operating expenses (including
exceptional items)
|
|
(2,082)
|
(352)
|
(2,434)
|
(3,337)
|
(333)
|
(3,670)
|
Loss from operations before
exceptional items
|
|
(1,144)
|
(148)
|
(1,292)
|
(2,863)
|
(97)
|
(2,960)
|
Exceptional items
|
3
|
(229)
|
-
|
(229)
|
(170)
|
-
|
(170)
|
Loss
from operations
|
|
(1,373)
|
(148)
|
(1,521)
|
(3,033)
|
(97)
|
(3,130)
|
Finance charge
|
|
(232)
|
(20)
|
(252)
|
(248)
|
(22)
|
(270)
|
Loss
before income tax
|
|
(1,605)
|
(168)
|
(1,773)
|
(3,281)
|
(119)
|
(3,400)
|
Income Tax
|
4
|
133
|
-
|
133
|
-
|
-
|
-
|
Loss
for the period
|
|
(1,472)
|
(168)
|
(1,640)
|
(3,281)
|
(119)
|
(3,400)
|
Loss
attributable to:
|
|
|
|
|
|
|
|
- Owners of the parent
company
|
|
(1,488)
|
(168)
|
(1,656)
|
(3,080)
|
(119)
|
(3,199)
|
- Non-controlling interest
|
|
16
|
-
|
16
|
(201)
|
-
|
(201)
|
|
|
(1,472)
|
(168)
|
(1,640)
|
(3,281)
|
(119)
|
(3,400)
|
Loss
per share attributable to the equity holders of the
Company:
|
|
|
|
|
|
|
|
Basic and diluted loss per
share
|
5
|
|
|
(0.23)p
|
|
|
(1.55)p
|
|
|
|
|
|
|
|
|
There is no other comprehensive
income for the period.
Group statement of financial position
As at 31 March 2024
|
Note
|
31 March
2024
Unaudited
£'000
|
30
September
2023
Audited
£'000
|
Assets
|
|
|
|
Non-current assets
|
|
|
|
Intangible Assets
|
6
|
2,768
|
2,763
|
Property, plant and
equipment
|
|
2,907
|
3,443
|
Trade and other
receivables
|
|
36
|
36
|
|
|
5,711
|
6,242
|
Current assets
|
|
|
|
Inventory
|
|
1,095
|
1,528
|
Trade and other
receivables
|
|
1,524
|
1,409
|
Assets held for sale
|
7
|
1,005
|
604
|
Cash and cash equivalents
|
|
675
|
596
|
|
|
4,299
|
4,137
|
Total assets
|
|
10,010
|
10,379
|
Equity
|
|
|
|
Called up share capital - ordinary
shares
|
|
149
|
3,308
|
Called up share capital - deferred
shares
|
|
3,423
|
-
|
Share premium
|
|
37,853
|
36,724
|
Merger reserve
|
|
1,256
|
1,256
|
Share-based payment
reserve
|
|
5,435
|
5,289
|
Accumulated losses
|
|
(45,037)
|
(43,382)
|
Equity attributable to owners of the
parent company
|
|
3,079
|
3,195
|
Non-controlling interest
|
|
(2, 099)
|
(2,115)
|
Total equity
|
|
980
|
1,080
|
Liabilities
|
|
|
|
Non-current liabilities
|
|
|
|
Trade and other payables
|
|
590
|
501
|
Deferred taxation
|
|
-
|
6
|
Innovate Loan
|
|
5,000
|
5,000
|
Long-term borrowings
|
|
726
|
995
|
|
|
6,316
|
6,502
|
Current liabilities
|
|
|
|
Trade and other payables
|
|
1,098
|
1,479
|
Invoice discounting
advances
|
|
211
|
762
|
Current portion of long-term
borrowings
|
|
488
|
556
|
Liabilities held for sale
|
7
|
917
|
-
|
|
|
2,714
|
2,797
|
Total liabilities
|
|
9,030
|
9,299
|
Total equity and liabilities
|
|
10,010
|
10,379
|
Statement of Group cash flows
For the 6 months ended 31 March
2024
|
6 months
ended
31 March
2024
Unaudited
£'000
|
6 Months
ended
31
March
2023
Unaudited
£'000
|
Cash flows from operating activities
|
|
|
Cash used in operations
|
(658)
|
(1,561)
|
Interest paid
|
(114)
|
(270)
|
Net
cash used in operating activities
|
(772)
|
(1,831)
|
Cash flows from investing activities
|
|
|
|
|
|
Purchase/capitalisation of
intangible assets
|
(17)
|
(98)
|
Purchase of property, plant and
equipment
|
(1)
|
(45)
|
Net
cash used in investing activities
|
(18)
|
(143)
|
Cash flows from financing activities
|
|
|
Share issue
|
1,470
|
2,040
|
Share issue costs
|
(77)
|
(21)
|
Net funds (paid)/received from
CBILS
|
(38)
|
(52)
|
Principal payment of leases under
IFRS 16
|
(240)
|
(347)
|
Invoice discounting loan
(repayments)/proceeds
|
(224)
|
(235)
|
Net
cash generated from financing activities
|
891
|
1,385
|
Increase in cash and cash equivalents
|
101
|
(589)
|
Cash and cash equivalents at start
of period
|
596
|
1,351
|
Cash and cash equivalents at end of period
|
697
|
762
|
Note
to the statement of Group cash flows
For the 6 months ended 31 March
2023
|
6 months
ended
31 March
2024
Unaudited
£'000
|
6 months
ended
31
March
2023
Unaudited
£'000
|
Loss before income tax
|
(1,773)
|
(3,400)
|
Adjustments for:
|
|
|
Share-based payments
|
147
|
264
|
Depreciation
|
347
|
534
|
Amortisation
|
12
|
149
|
Finance cost
|
252
|
270
|
R&D Tax credit
received
|
133
|
-
|
Increase/(Decrease) in trade and
other receivables and investments
|
(110)
|
200
|
(Increase)/Decrease in
inventories
|
239
|
156
|
(Decrease)/Increase in trade and
other payables
|
95
|
266
|
Cash
used in operations
|
(658)
|
(1,561)
|
Discontinued operations
|
6 months
ended
31 March
2024
Unaudited
£'000
|
6 months
ended
31
March
2023
Unaudited
£'000
|
Net cash generated/(used) in
operating activities
|
102
|
215
|
Net cash used in investing
activities
|
-
|
-
|
Net cash generated/(used) from
financing activities
|
(93)
|
(216)
|
Increase/(decrease) in cash and cash equivalents from
discontinued operations
|
9
|
(1)
|
Notes to the unaudited interim statements
For the 6 months ended 31 March
2024
1.
Basis of preparation
Versarien Plc is an AIM quoted
company incorporated and domiciled in the United Kingdom under the
Companies Act 2006. The Company's registered office is Units 1A-D,
Longhope Business Park, Monmouth Road,
Longhope, Gloucestershire, GL17
0QZ.
The interim financial statements
were prepared by the Directors and approved for issue on 6 June
2024. These interim financial statements do not comprise statutory
accounts within the meaning of section 434 of the Companies Act
2006. Statutory accounts for the year ended 30 September 2023 were
approved by the Board of Directors on 27 March 2024 and delivered
to the Registrar of Companies. The report of the auditors on those
accounts was unqualified and did not contain statements under
sections 498 (2) or (3) of the Companies Act 2006. The report
contained reference to a material uncertainty related to going
concern.
As permitted, these interim
financial statements have been prepared in accordance with UK AIM
Rules and UK-adopted IAS 34, "Interim Financial Reporting". They
should be read in conjunction with the annual financial statements
for the year ended 30 September 2023, which have been prepared in
accordance with UK-adopted international accounting standards,
consistent with the IFRS framework adopted in UK law. The
accounting policies applied are consistent with those of the annual
financial statements for the period ended 30 September 2023, as
described in those financial statements. Where new standards or
amendments to existing standards have become effective during the
year, there has been no material impact on the net assets or
results of the Group.
These interim financial statements
have been prepared on a going concern basis under the historical
cost convention.
However, whilst the Company
continues to develop and seek to commercialise its graphene
technology it remains reliant upon the capital markets and/or asset
sales to continue as a going concern up until such time as it
generates sufficient revenues to cover its costs.
The Directors have prepared detailed
projections of expected future cash flows for a period of twelve
months from the date of issue of these interim results and have
made the following assumptions in support of adopting the going
concern basis in preparation of these interim results:
· Versarien will be able to raise
cash on the capital markets. There is no certainty as to timing or
quantum, but the Company has a history of raising capital on a
regular basis. The Company meets the criteria for EIS/VCT
investment which potentially widens the capital pool it may
access.
·The
Company will be able to sell its mature businesses having already
sold its Korean plant with receipts due on a staged
basis.
In making their going concern
assessment, the Directors have forecast that sufficient additional
funding will be raised to enable the Group to meet liabilities as
they fall due for a period of at least 12 months from the date of
issue of these interim results.
After due consideration, the
Directors have concluded that it is appropriate to prepare the
financial statements on a going concern basis subject to raising
the required funds either through asset sales and/or raising
sufficient equity.
The auditors' report on the Annual
Report and Financial Statements for the period ended 30 September
2023 was unqualified, did not contain a statement under s498(2) or
s498(3) of the Companies Act 2006 but drew attention to material
uncertainty with regard to going concern, details of which are
described in the Annual Report for 2023 which is available on the
Company's website.
Certain statements within this
report are forward looking. The expectations reflected in these
statements are considered reasonable. However, no assurance can be
given that they are correct. As these statements involve risks and
uncertainties the actual results may differ materially from those
expressed or implied by these statements. The interim financial
statements have not been audited.
2.
Segmental information
The segmental analysis for the 6
months to 31 March 2024 is as follows:
|
Central
|
Technology
Businesses
|
Mature
Businesses
|
Intra-group
Adjustments
|
Discontinued
operations
|
TOTAL
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
|
|
Revenue
|
-
|
277
|
1,061
|
-
|
1159
|
2,497
|
Gross Margin
|
-
|
138
|
366
|
-
|
204
|
708
|
Other operating income
|
-
|
202
|
3
|
-
|
-
|
205
|
Operating expenses
|
(616)
|
(872)
|
(590)
|
(4)
|
(352)
|
(2,434)
|
(Loss)/ profit from operations
|
(616)
|
(532)
|
(221)
|
(4)
|
(148)
|
(1,521)
|
Finance income/(charge)
|
(173)
|
(31)
|
(28)
|
-
|
(20)
|
(252)
|
(Loss)/profit before tax
|
(789)
|
(563)
|
(249)
|
(4)
|
(168)
|
(1,773)
|
The segmental analysis for the 6
months to 31 March 2023 is as follows:
|
Central
|
Technology
Businesses
|
Mature
Businesses
|
Intra-group
Adjustments
|
Discontinued
operations
|
TOTAL
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
|
|
Revenue
|
-
|
87
|
1,313
|
-
|
1,221
|
2,621
|
Gross Margin
|
-
|
(277)
|
524
|
-
|
236
|
483
|
Other operating income
|
-
|
54
|
3
|
-
|
-
|
57
|
Operating expenses
|
(916)
|
(1,801)
|
(614)
|
(6)
|
(333)
|
(3,670)
|
(Loss)/ profit from operations
|
(916)
|
(2,024)
|
(87)
|
(6)
|
(97)
|
(3,130)
|
Finance income/(charge)
|
(170)
|
(39)
|
(39)
|
-
|
(22)
|
(270)
|
(Loss)/profit before tax
|
(1,086)
|
(2,063)
|
(126)
|
(6)
|
(119)
|
(3,400)
|
3.
Exceptional items
Exceptional items of £229,000 relate
principally turnaround costs and former director gardening leave
costs (2023: £170,000 redundancy costs principally in relation to
the closure of Versarien Graphene Inc.)
4.
Taxation
The tax credit of £133,000 (2023:
£nil) relates to R&D tax credits received in the period. The
charge on the results for the period has been estimated at £nil
(2023: £nil). At the last year end the Group had £33.35 million of
trading losses carried forward to set-off against future trading
profits.
5.
Loss per share
The loss per share has been
calculated by dividing the loss after taxation of £1,656,000 (2023:
£3,199,000) by the weighted average number of shares in issue of
710,245,315 (2023: 205,983,636) during the period.
The calculation of the diluted
earnings per share is based on the basic earnings per share
adjusted to allow for the issue of shares on the assumed conversion
of all dilutive options. However, in accordance with IAS33
"Earnings per Share", potential Ordinary shares are only considered
dilutive when their conversion would decrease the profit per share
or increase the loss per share. As at 31 March 2024 there were
7,206,160 (2023: 15,205,850) potential ordinary shares that have
been disregarded in the calculation of diluted earnings per share
as they were considered non-dilutive at that date.
6.
Intangible assets
|
31 March
2024
Unaudited
£'000
|
30
September
2023
Audited
£'000
|
Patents, trademarks and
other
|
484
|
479
|
Development costs
|
2,284
|
2,284
|
Total
|
2,768
|
2,763
|
7. Assets and liabilities held
for sale
The sale process for AAC Cyroma is
progressing, albeit with no certainty of conclusion and
consequently its assets and liabilities are disclosed on a "held
for sale" basis.
|
|
|
31 March
2024
Unaudited
AAC Cyroma
£'000
|
30
September
2023
Audited
Korean
Plant
£'000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current assets
|
|
|
|
|
|
|
Intangible Assets
|
|
|
-
|
-
|
|
|
Property, plant and
equipment
|
|
|
190
|
604
|
|
|
Trade and other
receivables
|
|
|
-
|
-
|
|
|
|
|
190
|
604
|
|
Current assets
|
|
|
|
|
|
Inventory
|
|
|
194
|
-
|
|
Trade and other
receivables
|
|
|
599
|
-
|
|
Cash and cash equivalents
|
|
|
22
|
-
|
|
|
|
|
815
|
-
|
|
Assets held for sale
|
|
|
1,005
|
604
|
|
Liabilities
|
|
|
|
|
|
Non-current liabilities
|
|
|
|
|
|
Trade and other payables
|
|
|
-
|
-
|
|
Deferred taxation
|
|
|
-
|
-
|
|
Innovate Loan
|
|
|
-
|
-
|
|
Long-term borrowings
|
|
|
37
|
-
|
|
|
|
|
37
|
-
|
|
Current liabilities
|
|
|
|
|
|
Trade and other payables
|
|
|
530
|
-
|
|
Invoice discounting
advances
|
|
|
327
|
-
|
|
Current portion of long-term
borrowings
|
|
|
23
|
-
|
|
|
|
|
880
|
-
|
|
Liabilities held for sale
|
|
|
917
|
-
|
|
8.
Interim Report
This interim announcement is
available on the Group's website at www.versarien.com